Skip to content

The Effect of Alfa-Adrenergic Receptor Blockade on Insulin-Stimulated Forearm Glucose Uptake and Metabolism in Chronic Heart Failure

The Effect of a-Adrenergic Receptor Blockade on Insulin-Stimulated Forearm Glucose Uptake and Metabolism in Chronic Heart Failure

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00132106
Enrollment
Unknown
Registered
2005-08-19
Start date
2005-08-31
Completion date
Unknown
Last updated
2007-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure, Congestive

Brief summary

The activity of the sympathetic nervous system seems to influence the uptake (and handling) of glucose by the skeletal muscle of the forearm. Conditions in which sympathetic activity is increased seem to inhibit/reduce forearm glucose uptake. Inversely a decrease in sympathetic activity seems to increase glucose uptake. This study analyzes the effect of alfa-adrenergic receptor blockade (counteracting sympathetic influence) on insulin-stimulated forearm glucose uptake in patients with increased sympathetic activity (patients with chronic heart failure).

Interventions

Sponsors

ZonMw: The Netherlands Organisation for Health Research and Development
CollaboratorOTHER
Radboud University Medical Center
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Heart failure of at least New York Heart Association (NYHA) class II * Left ventricular ejection fraction (LVEF) \<= 40% * Age 18-75 years

Exclusion criteria

* Alfa-blockers, or beta-blockers with alfa-blocking activity (carvedilol) * Tricyclic antidepressants * Warfarin derivatives (acetylic salicylic acid and clopidogrel are allowed) * Hospitalisation in 6 weeks prior to the study * Any change in medication in 6 weeks prior to the study * Unstable angina * Orthopnoea * Known chronic disease of the autonomic nervous system * Diabetes mellitus * Oedema of the lower extremities, complicating the insertion of a venous catheter in a vein on the foot

Design outcomes

Primary

MeasureTime frame
change in glucose uptake

Countries

Netherlands

Contacts

Primary ContactMarc E.R. Gomes, MD
m.gomes@cardio.umcn.nl+31-24-3614533/3616550

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026